发明名称 COMPOUNDS AND METHODS OF TREATING OCULAR DISORDERS
摘要 <p>Abstract: A method of treating an ocular disorder in a subject associated with aberrant all-trans-retinal clearance in the retina, the method comprising administering to the subject a therapeutically effective amount of a primary amine compound of formula: wherein R1 is an aliphatic and/or aromatic compound; the primary amine compound upon administration to the subject forming a reversible Schiff-base with the all-trans-retinal or its metabolite in-chiding A2E and retinal dimer without adversely affecting normal retinoid cycle performance; the primary amine compound when administered to a Rdh8-'- Abca4-,- mouse increasing the optical coherence tomography score of the mouse to at least about 2.5 and increasing II-ds-retinal amount at least about 30% in comparison to untreated control animal, wherein the primary amine compound is not a local anesthetic, which includes an aromatic amine, that demonstrates sodium channel blockade when administered to the subject. 2218156v1</p>
申请公布号 AU2015201077(A1) 申请公布日期 2015.03.19
申请号 AU20150201077 申请日期 2015.03.03
申请人 CASE WESTERN RESERVE UNIVERSITY 发明人 PALCZEWSKI, KRZYSZTOF;MAEDA, AKIKO;GOLCZAK, MARCIN
分类号 A61K9/20;A61K9/22;A61K31/4162;A61K31/4184;A61K31/428;A61K31/56;A61P27/02 主分类号 A61K9/20
代理机构 代理人
主权项
地址